Natco settles patent suit with Gilead, others over Tamiflu
Natco Pharma and its partner Alvogen today said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news